ME MPJE key terms

A state-operated electronic database that tracks dispensed controlled substances. Pharmacists must generally review it before dispensing certain scheduled drugs and report dispensing data within a set time, though rules vary by state.

The pharmacist's independent federal duty to judge whether a prescription was issued for a legitimate medical purpose in the usual course of professional practice before dispensing a controlled substance, even if the prescriber is properly registered.

Warning signs suggesting a prescription may be invalid or diverted, such as long travel distance, cash payment, early refills, or patterns of the same drug from multiple prescribers. They trigger pharmacist inquiry before dispensing.

A drug or chemical regulated under federal scheduling law because of abuse or dependence potential. Schedules II through V carry progressively less restriction, and states may add stricter requirements on top of federal ones.

The most tightly controlled drug category available by prescription, covering substances with high abuse potential and accepted medical use. Federal rules generally bar refills, require written or qualifying electronic prescriptions, and impose strict storage and recordkeeping.

Electronic prescribing of controlled substances using software that meets federal identity-proofing and security standards. Practitioners need permitted credentials, and pharmacies must verify the prescription's required elements before dispensing.

The federal registration that authorizes a practitioner or pharmacy to handle controlled substances. It must be renewed periodically, kept at the registered location, and matched to the schedules and activities actually performed.

The federal order form used to transfer Schedule I and II controlled substances between registrants. It requires proper execution and record retention, and electronic ordering systems now substitute for the paper version.

A count of all controlled substances on hand that a registrant must complete every two years. Records must be kept and made available for inspection, and newly scheduled drugs must be added when they appear.

An ongoing running record of controlled substance receipts and disbursements that lets a pharmacy reconcile expected versus actual stock. Many states require it, and it supports detection of theft or loss.

The federal report used to notify the DEA of theft or significant loss of controlled substances. Registrants must file it promptly and also alert local authorities when required by state rules.

Dispensing less than the full quantity prescribed. Federal rules allow it for Schedule II under specific conditions such as patient or prescriber request, with remaining quantities subject to strict time limits and documentation.

An additional dispensing of a prescription without a new prescriber authorization. Federal law bars refills of Schedule II drugs and limits refills of Schedule III and IV drugs, with state rules sometimes stricter.

An orally communicated Schedule II order permitted in a genuine emergency. The pharmacist may dispense limited quantity, but the prescriber must supply a valid written or electronic prescription within a short federal deadline.

Moving an unfilled or partially filled prescription between pharmacies so it can be dispensed elsewhere. Federal rules permit limited transfers of controlled substance prescriptions, and states set their own procedures.

The information a dispensed prescription container must show, such as patient name, drug, directions, quantity, and pharmacy details. Federal and state laws both apply, and states often add specific warnings.

The pharmacist's discussion with the patient about proper use, risks, and storage of a dispensed drug. Federal rules require an offer to counsel, and states may mandate actual counseling or define exceptions.

A FDA-approved patient handout required for certain drugs with serious risks. Pharmacists must provide it with each dispensing, and it supplements rather than replaces required counseling.

The documentation a pharmacy must keep for each prescription, including prescriber, patient, drug, quantity, date, and dispensing pharmacist. Retention periods and required contents are set by federal and state rules.

Maintaining required pharmacy documents such as prescription files, controlled substance inventories, invoices, and inspection logs. Records must be readily retrievable, kept for the mandated period, and available to regulators.

A documented chain of custody for a prescription drug showing each prior owner and transaction. Federal law requires it for certain drugs, and states may impose additional tracking obligations.

Federal law establishing a system to trace prescription drugs through the supply chain. It requires transaction documentation, verification of trading partners, and handling of suspect or illegitimate product.

Preparing a customized medication from ingredients to meet a specific patient's need. Federal law distinguishes traditional compounding from outsourcing, and states regulate pharmacy compounding practices and equipment.

A set of standards for sterile compounding that addresses facilities, personnel training, environmental monitoring, and beyond-use dating. Many states adopt it by reference in their pharmacy regulations.

Providing a drug to a patient under a valid prescription, including review, preparation, labeling, and counseling. It requires a pharmacist's judgment and compliance with both federal and state requirements.

The pharmacist responsible for a pharmacy's overall compliance with drug laws and regulations. Duties often include recordkeeping oversight, staff training, and ensuring inspection readiness.

The state authorization for a pharmacy to operate at a specific location under a responsible pharmacist. It must be renewed, displayed, and amended when ownership or location changes.

The state credential allowing a person to practice pharmacy, granted after education, examination, and background requirements. It requires renewal and continuing education and may be disciplined for violations.

Required ongoing professional learning that pharmacists must complete to renew a license. States set hour totals, topic mandates, and documentation rules, and some require specific subject areas such as law.

The state credential that allows a pharmacy student or graduate to gain practical experience under supervision. It typically carries hour and supervision requirements and must be renewed separately from licensure.

The state credential permitting a technician to assist with pharmacy tasks under pharmacist supervision. Requirements, allowed duties, and supervision ratios vary by jurisdiction.

The process by which a pharmacist licensed in one state obtains licensure in another, often through score transfer or endorsement. Eligibility and additional requirements depend on the receiving state.

Conduct that can lead to license suspension, revocation, or other sanctions, such as fraud, impaired practice, or unprofessional conduct. Boards investigate complaints and impose penalties under state law.

The procedural protections a licensee receives in disciplinary or licensing actions, including notice, a hearing, and the chance to respond. These safeguards apply before a board imposes serious sanctions.

Dispensing a therapeutically equivalent lower-cost product in place of a prescribed brand drug. State law generally permits it unless the prescriber prohibits substitution, and patient notification rules apply.

Whether a prescription meets legal requirements such as a legitimate medical purpose, proper prescriber authority, and required elements. A pharmacist may decline to fill an invalid or questionable prescription.

The date after which a prescription may no longer be dispensed. Federal rules limit Schedule II prescriptions and refill windows for other controlled drugs, while states may set shorter periods.

A written authorization letting another person act on a registrant's behalf for specified controlled substance transactions. Federal rules require execution and retention of the document.

The obligation to notify regulators when controlled substances go missing. Federal and state rules set timing, forms, and follow-up duties, and failure to report can itself be a violation.